IRIS UniCatt

Giaccari, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.775
AS - Asia 5.087
EU - Europa 4.813
SA - Sud America 1.005
AF - Africa 135
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 4
Totale 17.840
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.587
SG - Singapore 2.251
CN - Cina 1.169
DE - Germania 893
BR - Brasile 840
IT - Italia 835
PL - Polonia 672
SE - Svezia 553
VN - Vietnam 522
FR - Francia 463
UA - Ucraina 285
GB - Regno Unito 262
FI - Finlandia 202
IE - Irlanda 201
IN - India 178
ID - Indonesia 142
RU - Federazione Russa 142
JP - Giappone 134
BD - Bangladesh 125
TR - Turchia 118
HK - Hong Kong 116
CA - Canada 91
AR - Argentina 65
NL - Olanda 63
MX - Messico 59
IQ - Iraq 51
AT - Austria 43
KR - Corea 43
ES - Italia 32
ZA - Sudafrica 32
AE - Emirati Arabi Uniti 31
EC - Ecuador 30
BE - Belgio 29
PK - Pakistan 26
SA - Arabia Saudita 25
MA - Marocco 22
IR - Iran 19
UZ - Uzbekistan 19
AU - Australia 18
CH - Svizzera 18
KE - Kenya 16
LT - Lituania 16
RO - Romania 16
PY - Paraguay 15
EG - Egitto 13
MY - Malesia 13
AZ - Azerbaigian 12
DZ - Algeria 12
GR - Grecia 12
VE - Venezuela 12
CO - Colombia 11
CZ - Repubblica Ceca 11
KZ - Kazakistan 10
PE - Perù 10
PH - Filippine 10
CL - Cile 9
DK - Danimarca 9
JO - Giordania 9
AL - Albania 8
BG - Bulgaria 8
IL - Israele 8
JM - Giamaica 8
OM - Oman 8
DO - Repubblica Dominicana 7
PT - Portogallo 7
UY - Uruguay 7
BY - Bielorussia 6
NG - Nigeria 6
NP - Nepal 6
SN - Senegal 6
BH - Bahrain 5
CI - Costa d'Avorio 5
HN - Honduras 5
KG - Kirghizistan 5
TH - Thailandia 5
TN - Tunisia 5
TW - Taiwan 5
CR - Costa Rica 4
HR - Croazia 4
MD - Moldavia 4
PA - Panama 4
SI - Slovenia 4
TT - Trinidad e Tobago 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
BO - Bolivia 3
GE - Georgia 3
KH - Cambogia 3
KW - Kuwait 3
LV - Lettonia 3
MZ - Mozambico 3
QA - Qatar 3
RS - Serbia 3
BJ - Benin 2
CG - Congo 2
ET - Etiopia 2
HU - Ungheria 2
IS - Islanda 2
LB - Libano 2
LY - Libia 2
Totale 17.810
Salva come PNG Salva come JPEG
Città #
Singapore 1.166
Ashburn 732
Chandler 708
San Jose 626
Warsaw 580
Rome 257
Beijing 223
Fairfield 215
Dublin 198
Wilmington 186
New York 183
Houston 178
Ho Chi Minh City 177
Los Angeles 164
San Mateo 156
Milan 148
Jacksonville 147
Hefei 139
Lauterbourg 137
Hanoi 128
Tokyo 123
Seattle 122
Jakarta 120
Nanjing 107
Moscow 95
Hong Kong 94
Woodbridge 92
São Paulo 86
Ann Arbor 84
Frankfurt am Main 83
Helsinki 83
Boston 82
Council Bluffs 81
Kraków 79
The Dalles 79
Chicago 77
Izmir 75
St Louis 70
Princeton 67
Munich 65
Dearborn 64
Dallas 58
Cambridge 54
Santa Clara 52
Buffalo 51
Bremen 49
Hangzhou 46
London 44
Redwood City 42
Boardman 39
Kent 39
Lappeenranta 38
Cattolica 37
Marseille 37
Seoul 37
Nuremberg 35
Turku 35
Mountain View 34
Nanchang 31
Tianjin 31
Vienna 31
Chennai 30
Falls Church 29
Brooklyn 28
Nürnberg 28
Orem 28
Shanghai 28
North Bergen 27
Phoenix 27
Toronto 27
Brussels 26
Haiphong 26
Rio de Janeiro 25
Amsterdam 24
Paris 24
Da Nang 23
Lancaster 23
Lawrence 23
Redmond 23
Curitiba 22
Denver 22
Stockholm 22
Düsseldorf 21
Johannesburg 21
Mexico City 21
Atlanta 20
Belo Horizonte 20
Busto Arsizio 20
Guangzhou 18
Kunming 18
Miami 18
Montreal 18
Norwalk 18
Poplar 18
San Francisco 18
Sharjah 18
Tashkent 18
Baghdad 17
Jiaxing 17
Manchester 17
Totale 9.967
Salva come PNG Salva come JPEG
Nome #
HCC development is associated to peripheral insulin resistance in a mouse model of NASH 381
Efficacy and safety of dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in diabetes mellitus. 348
Effect of Vitamin D Supplementation on Obesity-Induced Insulin Resistance: A Double-Blind, Randomized, Placebo-Controlled Trial 331
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 313
Comment on: Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) 281
Sotagliflozin, the first dual SGLT inhibitor: Current outlook and perspectives 11 Medical and Health Sciences 1103 Clinical Sciences 277
Sotagliflozin Added to Optimized Insulin Therapy Leads to Lower Rates of Clinically Relevant Hypoglycemic Events at Any HbA1c at 52 Weeks in Adults with Type 1 Diabetes 258
High-normal TSH values in obesity depends on adipose tissue rather than insulin resistance 255
In anorexia nervosa, even a small increase in abdominal fat is responsible for the appearance of insulin resistance 238
Advancing Diabetes Research: a novel islet isolation method from living donors. 231
METABOLIC SYNDROME IN TRANSPLANT PATIENTS: AN UPDATING POINT OF VIEW 219
β-Cell Fate in Human Insulin Resistance and Type 2 Diabetes: A Perspective on Islet Plasticity 197
Pancreaticoduodenectomy model demonstrates a fundamental role of dysfunctional β cells in predicting diabetes 192
β-Cell Glucose Sensitivity Is Linked to Insulin/Glucagon Bihormonal Cells in Nondiabetic Humans. 191
A Rare Case of Ectopic Adrenocorticotropic Hormone Syndrome Caused by a Metastatic Neuroendocrine Tumor of the Pancreas Detected by 68Ga-DOTANOC and 18F-FDG PET/CT 189
Endocrine and Metabolic Insights from Pancreatic Surgery 188
Removal of Duodenum Elicits GLP-1 Secretion 186
Metabolic consequences of the occlusion of the main pancreatic duct with acrylic glue after pancreaticoduodenectomy 184
Effect of Dapagliflozin on Myocardial Insulin Sensitivity and Perfusion: Rationale and Design of The DAPAHEART Trial 182
The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach 181
In humans increase in intrapancreatic adipose tissue predicts beta-cell dedifferentiation score before diabetes onset: A pilot study 180
The size of adrenal incidentalomas correlates with insulin resistance. Is there a cause-effect relationship? 179
D-carnosine octylester attenuates atherosclerosis and renal disease in ApoE null mice fed a Western diet through reduction of carbonyl stress and inflammation 178
Low levels of 25(OH)D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS? 172
Increased B-cell workload modulates proinsulin-to-insulin ratio in humans 171
Hypovitaminosis D Is Associated with Liver Insulin Resistance in Obese Subjects 170
Metabolic syndrome in transplant patients: an academic or a health burden? 167
Will vitamin D reduce insulin resistance? Still a long way to go 167
Insulin resistance alters islet morphology in nondiabetic humans 167
25-Hydroxyvitamin D concentration correlates with insulin-sensitivity and BMI in obesity 164
Single-fiber conduction velocity test allows earlier detection of abnormalities in diabetes 161
Beta-cell function and glucose metabolism in patients with chronic pancreatitis 159
High-normal TSH values in obesity: is it insulin resistance or adipose tissue's guilt? 159
Spotlight on ertugliflozin and its potential in the treatment of type 2 diabetes: Evidence to date 159
Can vitamin D deficiency cause diabetes and cardiovascular diseases? Present evidence and future perspectives 154
First-phase insulin secretion: can its evaluation direct therapeutic approaches? 151
Noradrenergic fibers are associated with beta-cell dedifferentiation and impaired beta-cell function in humans 149
Prediabetes: how pathophysiology drives potential intervention on a subclinical disease with feared clinical consequences 146
Beta-cell function and glucose metabolism in patients with chronic pancreatitis 145
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial 144
IL-21 is a major negative regulator of IRF4-dependent lipolysis affecting Tregs in adipose tissue and systemic insulin sensitivity 143
Continuous subcutaneous insulin infusion (CSII) in inpatient setting: unmet needs and the proposal of a CSII unit 142
Vitamin D deficiency: a new risk factor for type 2 diabetes? 142
β α-Cell glucose sensitivity is linked to insulin/glucagon bihormonal cells in nondiabetic humans 140
Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus 139
Association of vitamin D with insulin resistance and β-cell dysfunction in subjects at risk for type 2 diabetes: Comment to Kayaniyil et al. 138
Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): A multicenter retrospective nationwide Italian study and crowdsourcing opportunity 138
Alpha-Lipoic Acid and Glucose Metabolism: A Comprehensive Update on Biochemical and Therapeutic Features 137
The interplay of extracellular vesicles in the pathogenesis of metabolic impairment and type 2 diabetes 137
The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3. 136
Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study 136
Altered BAG3-insulin colocalization is associated with impaired first phase insulin secretion in humans 135
A novel low-density lipoprotein receptor variant in a Ukrainian patient: a case report and overview of the disease-causing low-density lipoprotein receptor variants associated to familial hypercholesterolemia 133
A single bout of physical exercise improves 1-hour post-load plasma glucose in healthy young adults 132
Galectin-3 gene deletion results in defective adipose tissue maturation and impaired insulin sensitivity and glucose homeostasis 132
Erythrocyte membrane fluidity: A novel biomarker of residual cardiovascular risk in type 2 diabetes 129
Metformin Benefits: Another Example for Alternative Energy Substrate Mechanism? 129
Physical Activity and Type 2 Diabetes: In Search of a Personalized Approach to Improving β-Cell Function 127
Lynch Syndrome and Thyroid Nodules: A Single Center Experience 127
Potential cause-effect relationship between insulin autoimmune syndrome and alpha lipoic acid: Two case reports 126
Position Statement on the management of continuous subcutaneous insulin infusion (CSII): The Italian Lazio experience 126
Bile modulates secretion of incretins and insulin: a study on human extrahepatic cholestasis 125
Phenotype modulation in cultures of vascular smooth muscle cells from diabetic rats: association with increased nitric oxide synthase expression and superoxide anion generation 124
Postoperative hyperglycemia affects survival after gastrectomy for cancer: A single-center analysis using propensity score matching 124
Reduced incretin effect precedes diabetes development following duodenopancreatectomy in individuals without diabetes 123
Intra-islet insulin synthesis defects are associated with endoplasmic reticulum stress and loss of beta cell identity in human diabetes 122
Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes 122
Glucose toxicity: the leading actor in the pathogenesis and clinical history of type 2 diabetes - mechanisms and potentials for treatment 122
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 122
Altered GIP/GLP-1 Secretion Ratio is Associated With Impaired β Cell Function in Humans 121
Dapagliflozin improves myocardial flow reserve in patients with type 2 diabetes: the DAPAHEART Trial: a preliminary report 120
Erythrocyte Membrane Fluidity and Omega-3 Fatty Acid Intake: Current Outlook and Perspectives for a Novel, Nutritionally Modifiable Cardiovascular Risk Factor 120
MetaLiverCat: the NAFLD/NASH multidisciplinary board at Fondazione Policlinico Gemelli IRCCS 120
The Interplay between Immune System and Microbiota in Diabetes 119
A systematic comparison of protocols for recovery of high-quality rna from human islets extracted by laser capture microdissection 119
First-phase insulin secretion: can its evaluation direct therapeutic approaches? 118
An update on pancreatic regeneration mechanisms: Searching for paths to a cure for type 2 diabetes 116
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 116
Cardiovascular events and all-cause mortality in patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors: An extensive meta-analysis of randomized controlled trials 116
Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat. 115
SGLT-2 inhibitors for treatment of heart failure in patients with and without type 2 diabetes: A practical approach for routine clinical practice 112
β-Adrenergic Responsive Induction of Insulin Resistance in Liver of Aging Rats 109
High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes. 108
Effect of sotagliflozin as an adjunct to insulin therapy on blood pressure and arterial stiffness in adults with type 1 diabetes: A post hoc pooled analysis of inTandem1 and inTandem2 106
A single-center prospective analysis of the impact of glucose metabolism on pancreatic fistula onset after pancreaticoduodenectomy for periampullary tumors 104
Exploring Nutraceutical Approaches Linking Metabolic Syndrome and Cognitive Impairment 104
FL-926-16, a novel bioavailable carnosinase-resistant carnosine derivative, prevents onset and stops progression of diabetic nephropathy in db/db mice 103
Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes 103
Peroxiredoxin 6, a novel player in the pathogenesis of diabetes 102
Early insulin treatment in type 2 diabetes: ORIGINal sin or valuable choice as ORIGINal treatment? An open debate on the ORIGIN study results 101
Management of diabetes in older adults 101
Rats that are made insulin resistant by glucosamine treatment have impaired skeletal muscle insulin receptor phosphorylation 99
Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study 98
Effects of PCSK9 inhibition on glucose metabolism and β-cell function in humans: a pilot study 96
Evaluation of guidelines on diabetes medication 96
Nuclear export of FoxO1 is associated with ERK signaling in β-cells lacking insulin receptors 95
Identification and Molecular Characterization of a Novel Large-Scale Variant (Exons 4_18 Loss) in the LDLR Gene as a Cause of Familial Hypercholesterolaemia in an Italian Family 93
Human subjects with impaired beta-cell function and glucose tolerance have higher levels of intra-islet intact GLP-1 92
Lysophosphatidylinositols Are Upregulated After Human β-Cell Loss and Potentiate Insulin Release 92
An update on pancreatic regeneration mechanisms: Searching for paths to a cure for type 2 diabetes 92
Totale 15.178
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.918
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.918
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202141 0 0 0 0 0 0 0 0 0 0 0 41
2021/20221.100 102 69 50 76 78 36 65 199 40 71 129 185
2022/20231.995 230 233 161 324 115 241 58 173 255 48 83 74
2023/20241.206 56 290 47 52 63 157 113 82 26 62 95 163
2024/20252.825 78 74 201 110 155 93 105 196 387 306 600 520
2025/20267.268 909 220 509 834 1.154 407 1.249 326 554 574 324 208
Totale 18.109